牛心包与猪生物瓣膜在二尖瓣置换中的比较:韩国全国队列研究结果
该研究基于韩国国民健康保险服务数据库,纳入2003至2018年接受生物瓣二尖瓣置换的成人患者,经倾向评分匹配和竞争风险分析比较牛心包瓣与猪瓣的临床结局。匹配后1170对患者分析显示,两组在全因死亡、心源性死亡及再次手术的累积发生率上均无显著差异(aHR分别为1.00、0.96、1.01)。
要点
- 匹配后牛心包瓣与猪瓣的全因死亡风险无显著差异(aHR 1.00,95%CI 0.87-1.14)。
- 心源性死亡风险两组无显著差异(aHR 0.96,95%CI 0.81-1.14)。
- 再次手术风险两组无显著差异(aHR 1.01,95%CI 0.72-1.41)。
核心结论
- 在全国性比较中,牛心包瓣与猪瓣用于二尖瓣置换的临床结局包括死亡率和瓣膜相关再次手术均无显著差异。
研究设计与样本
- 基于韩国国民健康保险服务数据库的全国性行政索赔数据研究,纳入2003至2018年接受生物瓣二尖瓣置换的成人患者,采用倾向评分匹配与竞争风险分析比较牛心包瓣与猪瓣,匹配后1170对进入最终分析。
主要发现
- 共3151例患者接受生物瓣二尖瓣置换,其中牛心包瓣1628例(51.7%),猪瓣1523例(48.3%)。
- 随访中位4.49年(四分位距1.87-8.75年),死亡1178例(6.8%/患者年),中心源性死亡730例(4.3%/患者年)。
- 匹配后牛心包组与猪组全因死亡累积发生率无显著差异(aHR 1.00,95%CI 0.87-1.14)。
- 两组心源性死亡累积发生率无显著差异(aHR 0.96,95%CI 0.81-1.14)。
- 两组再次手术累积发生率无显著差异(aHR 1.01,95%CI 0.72-1.41)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Comparisons of long-term clinical outcomes of mitral valve replacement (MVR) between bovine pericardial and porcine bioprostheses are conflicting, with limited research in large-scale real-world clinical settings. This study examined clinical outcomes in MVR according to bioprosthesis type using a national administrative claims database. METHODS: This study included adult patients undergoing bioprosthetic MVR between 2003 and 2018 using administrative health care data from the Korean National Health Insurance Service database. Propensity score matching with competing risk analysis was used to compare the clinical outcomes according to the type of bioprosthesis. The end points were death, cardiac death, and valve-related events, including the incidence of reoperation, endocarditis, systemic thromboembolism, and major bleeding. RESULTS: A total of 3151 patients underwent bioprosthetic MVR with bovine pericardial (n = 1628, 51.7%) or porcine (n = 1523, 48.3%) bioprostheses. After matching, 1170 pairs were included in the final analysis. During follow-up (median 4.49 years, interquartile range 1.87 -8.75 years), death occurred in 1178 patients (6.8%/patient-year), comprising 730 (4.3%/patient-year) cardiac death. No significant differences were noted between the bovine and porcine groups in the cumulative incidences of death from any cause [adjusted hazard ratio (aHR), 1.00; 95% confidence interval (CI), 0.87-1.14], cardiac mortality (aHR, 0.96; 95% CI, 0.81-1.14), or reoperation (aHR, 1.01; 95% CI, 0.72-1.41). CONCLUSIONS: This study on a nationwide comparison between bovine and porcine bioprostheses in MVR found no significant differences in clinical outcomes including mortality, and valve-related reoperation.
引用
- Kim HR, Park J, Park SJ, et al. Bovine pericardial versus porcine bioprosthetic mitral valves: results from a Korean Nationwide Cohort Study. Eur J Cardiothorac Surg. 2023. PMID: 37115646. doi:10.1093/ejcts/ezad165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。